Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203889 · ClinicalTrials.gov registry record · NA
Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03203889: Completed NA study, sponsored by University of New Mexico.
NCT03203889 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03203889, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
It is important to address the substantial substance-related health disparities of American Indians (AI). This project aims to examine the effectiveness of a culturally tailored Community Reinforcement and Family Training (CRAFT) approach and Twelve-step facilitation with Concerned Significant Others (TSF-CSOs) among AIs to increase engagement of treatment refusing individuals into treatment/healing and to reduce distress of their loved ones. Study hypotheses are that (1) CRAFT will result in higher numbers of people entering treatment for substance use disorders than will TSF-CSO, (2) both groups will yield similar improvements in the family member's functioning, and (3) we will explore potential factors of the treatments to see which aspects of the treatment are most important and to test which characteristics of the clients impact the outcomes for better or worse. This knowledge may impact dissemination and diffusion efforts for CRAFT-AI and other evidence-based treatments among AIs and other culturally diverse groups.
Primary Outcome
attending one session of formal substance use disorder treatment or one AI traditional healing session within 6 months of the CSO's 1st counseling session
Interventions
- BEHAVIORAL CRAFT-AI
- BEHAVIORAL TSF-CSO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2021-07-25 |
| Phase | NA |
What the finished NCT03203889 record still lists
NCT03203889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which CRAFT-AI is the first listed.
NCT03203889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03203889 about?
NCT03203889 is a clinical study titled "Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians". It is important to address the substantial substance-related health disparities of American Indians (AI). This project aims to examine the effectiveness of a culturally tailored Community Reinforcement and Family Training (CRAFT) approach and Twelve-step facilitation with Concerned Significant Other...
What is the current status of trial NCT03203889?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-06-27. Estimated completion is 2021-07-25.
What interventions are being tested in trial NCT03203889?
The interventions under investigation include: CRAFT-AI (BEHAVIORAL), TSF-CSO (BEHAVIORAL).
Who is sponsoring clinical trial NCT03203889?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03203889's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI